Clinical Trial Update: ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial [Phase 3]

View source ↗

Summary

A Phase 3 interventional trial evaluating an aldosterone antagonist for survival in patients with end-stage renal failure on dialysis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End Stage Renal Disease On Dialysis

Snippet

Sponsor: University Hospital, Brest | Conditions: End Stage Renal Failure on Dialysis | Phase 3 | Status: COMPLETED